Drug Profile
Research programme: CNS therapeutics - Titan Pharmaceuticals
Alternative Names: Lisuride implant; ProNeura-Lisuride implantLatest Information Update: 11 May 2017
Price :
$50
*
At a glance
- Originator Titan Pharmaceuticals
- Class Ergolines
- Mechanism of Action 5-HT1A serotonin receptor agonists; Dopamine D2 receptor agonists; Serotonin 2A receptor antagonists; Serotonin 2B receptor antagonists; Serotonin 2C receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Dyskinesias
Most Recent Events
- 11 May 2017 Discontinued - Preclinical for Dyskinesia in USA (SC)
- 09 Jul 2012 Preclinical development is ongoing in USA
- 31 Dec 2011 Preclinical development is ongoing in USA